EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
92 hedge funds and large institutions have $227M invested in Eiger BioPharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
92
Holding in Top 10
6
Calls
$2.22M
Puts
$905K
Top Buyers
| 1 | +$4.07M | |
| 2 | +$3.5M | |
| 3 | +$3.09M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$3M |
| 5 |
CA
CHI Advisors
New York
|
+$2M |
Top Sellers
| 1 | -$4.72M | |
| 2 | -$3.05M | |
| 3 | -$1.16M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$785K |
| 5 |
TI
Telemetry Investments
New York
|
-$749K |